Test Your Knowledge of RCC Research Presented at ESMO!
Do you remember the RCC research presented at ESMO 2024? Test your knowledge now and see how you rank!
Read More
Ad Code: Cabometyx - ESMO Display Banners Conference - CPE - OCT - 172977
ESMO eBook
A curated eBook featuring ESMO 2024 RCC-focused studies, findings, and expert opinions.
Read More
Real-World Outcomes of Immune-Oncology Combinations for Advanced RCC
Real-world evidence from this study suggests that ICI-TKI combinations may be optimal for intermediate-risk mRCC.
Read More
Renal Cell Carcinoma: Disease Detection, Translocation Monitoring, & More
Physician’s Weekly reviewed renal cell carcinoma-targeted research presented at the 2024 ESMO annual meeting.
Read More
ESMO 2024: Renal Cell Carcinoma Highlights
During the 2024 annual ESMO Congress, multiple poster sessions focused on the treatment of renal cell carcinoma (RCC).
Read More
Protein Glycosylation Predicts Resistance and Treatment Response in aRCC
Protein glycosylation may predict response to NIVO+CABO vs SUN in aRCC, with glycopeptides and complement proteins linked to progression-free survival and outcomes.
Read More
Immunotherapy Beats Standard Care in Metastatic Non-Clear Cell Renal Cancer
The SUNNIFORECAST trial (LBA75), presented by Dr. Lothar Bergmann from Germany on Friday,...
Read More
Did You Attend ESMO 2024 in Person?
Let us know if you attended ESMO 2024 in person.
Read More